Objective: To determine whether the presence of anti-cyclic citrullinated peptide (anti-CCP)
antibodies and rheumatoid factor immunoglobulin M (RF IgM) is associated with endothelial …

Background Rheumatoid arthritis (RA) is an independent risk factor for adverse
cardiovascular (CV) events that accounts for a significant proportion of mortality among …

Objectives. The purpose of this study was to determine the prevalence of anti-CCP
antibodies (anti-CCP Abs) and to assess associations between the presence of anti-CCP Ab …

The main cause of death in rheumatoid arthritis (RA) is cardiovascular events. We evaluated
the relationship of anticyclic citrullinated peptide (anti‐CCP) antibody levels with increased …

Objective: To determine the significance of quantitative levels of antibodies to cyclic
citrullinated peptides (anti-CCP) in a population of patients with rheumatoid arthritis (RA) …

Objective Macrophage migration inhibitory factor (MIF) and vascular endothelial growth
factor (VEGF), as crucial parameters of angiogenesis and inflammation, were evaluated to …

Objective Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular
disease that may not always be related to the presence of traditional cardiovascular risk …

Objective: To investigate the effect of infliximab treatment on anti-cyclic citrullinated peptide
antibodies (anti-CCP) and rheumatoid factor (RF) in patients with rheumatoid arthritis …

Aim: To determine the frequency of anti‐cyclic citrullinated peptide antibody (anti‐CCP) in a
group of patients with rheumatoid arthritis and another group with other rheumatic diseases …

OBJECTIVES: To evaluate frequency of anti-cyclic citrullinated peptide antibodies (anti-
CCP) in long-standing rheumatoid arthritis (LsRA) patients and their relationship with extra …